
Genome Editing USA Congress
10 – 11 May 2017, Boston, USA
Over 250 delegates representing the leading research & academic institutions and clinical research institutions in the USA, as well as leading pharmaceutical and biotech companies from around the globe.
Over 20 presentations dedicated to genome editing technologies and the applications of genome editing in a range of therapeutic areas, including muscular dystrophy, cardiovascular diseases, genetic disorders and immunotherapies.
Including interactive streams focusing on:
♦ Genome Editing Techniques
♦ Therapeutic Applications of Genome Editing
♦ Drug Discovery & Development Applications
Our 2017 Speakers Include:

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our Advances in Transgenic Technology USA Congress.
Free Pre-Congress Live Webinar
Advances in Transgenic Technology
Hosted by Nicholas Gale, Senior Director Therapeutic Target Discovery, Regeneron and Melissa Larson, Technical Director, Transgenic and Gene-Targeting Facility, University of Kansas Medical Centre